FORA Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

FORA Capital’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17,528	Closed	-$1.19M	–	670
2022 Q3	$1.19M	Buy	+17,528	New	+$967K	0.23%	137
2022 Q2	–	Sell	-8,005	Closed	-$280K	–	746
2022 Q1	$280K	Buy	+8,005	New	+$239K	0.05%	402
2020 Q2	–	Sell	-2,187	Closed	-$112K	–	1411
2020 Q1	$112K	Buy	+2,187	New	+$146K	0.02%	586

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

FORA Capital's GBT Position: Q4 2022 in Review

FORA Capital sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 17,528 shares — an estimated $1.19M sold.

FORA Capital first reported a position in GBT in Q1 2020 and held it in 3 quarters. The position peaked at $1.19M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

FORA Capital reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
FORA Capital sold 17,528 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.19M.
FORA Capital first reported a position in Global Blood Therapeutics, Inc. in Q1 2020 and held it in 3 quarters.
FORA Capital's Global Blood Therapeutics, Inc. position peaked at $1.19M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on FORA Capital's 13F filing for Q4 2022, filed 8 Feb 2023.